NASDAQ: JNP Investor Notice: Investigation of Takeover of Juniper Pharmaceuticals, Inc. by Catalent, Inc
The takeover of Juniper Pharmaceuticals, Inc. is under investigation concerning whether the takeover of Juniper Pharmaceuticals, Inc. by Catalent, Inc is unfair to NASDAQ: JNP stockholders.
View full press release